Congenica Receives CE Mark for Genomic Analysis Software
Congenica NGS data analysis software for genomic data interpretation is now CE marked under the In Vitro Diagnostics Directive.
Congenica funded to reduce fatal drug interactions by mapping genes
New software to reduce the number of adverse drug reactions is being developed thanks to a joint investment of £2 million provided by UKRI and L& G.
Congenica assures the clinical safety of NHS genomic analysis
Congenica clinical decision support and NGS data analysis provides a complete Clinical Risk Management Process in compliance with the DCB0129 standard
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Camtech will market, distribute, sell Congenica rapid NGS data analysis software and clinical decision support in Singapore, Malaysia, Japan, South Korea
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Digital health company Congenica, providing rapid and accurate genomic data analysis software, appoints new Chief Financial Officer, Jayesh Pankhania.
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health selects Congenica clinical decision support platform and NGS data analysis software to provide answers for undiagnosed rare disease patients
Congenica signs distribution agreement with AmpliTech in France
Congenica, the digital health company enabling rapid and accurate analysis of genomic data, announces a distribution agreement with AmpliTech.
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Congenica, the company enabling rapid and accurate NGS data analysis to transform lives, today announces the appointment of Kamraan Shariff.
David Atkins joins the National Genomics Board as BIA SME representative
David Atkins, CEO of NGS data analysis software company Congenica, has joined the National Genomics Board to advise on the UK national genomics strategy.
Inclusion in AJHG “Year in Review” 2020
The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, which includes a study featuring Congenica.
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General.